Aj Bergmann is the current Chief Financial Officer at Capricor Therapeutics. Aj has previous experience working as a financial analyst and client accountant/analyst. Aj Bergmann has a degree in accounting from the University of Southern California.
Aj Bergmann graduated with a Bachelor of Science in Management from Providence College and went on to earn an MBA in Entrepreneurship/Entrepreneurial Studies from the University of Southern California - Marshall School of Business.
Aj Bergmann reports to Linda Marbán, President, CEO & Director. They work with Kristi A. H. Elliott - VP, Research & Development, Daniel Paulson - VP, Clinical Development, and Xavier Avat - Chief Business Officer.
Current role